Get started
Author

Grace E. Mishkin

Observed names: G. Mishkin, Grace E Mishkin, Grace Mishkin, Mishkin, Grace
ORCID: 0000-0003-2466-332X
Observed ORCID: 0000-0003-2466-332X
OpenAlex ID: A5073732889
The generalizability of NCI-sponsored clinical trials accrual among women with gynecologic malignancies
2016 · Grace Mishkin, Lori M. Minasian, et al. · Gynecologic Oncology · 43
Challenges Facing Early Phase Trials Sponsored by the National Cancer Institute: An Analysis of Corrective Action Plans to Improve Accrual
2016 · Holly A. Massett, Grace Mishkin, et al. · Clinical Cancer Research · 37
Raising Public Awareness of Clinical Trials: Development of Messages for a National Health Communication Campaign
2017 · Holly A. Massett, David M. Dilts, et al. · Journal of Health Communication · 26
Meeting the Challenge: The National Cancer Institute’s Central Institutional Review Board for Multi-Site Research
2018 · Holly A. Massett, Sharon L. Hampp, et al. · Journal of Clinical Oncology · 21
Reporting of health‐related quality of life endpoints in National Cancer Institute–supported cancer treatment trials
2020 · Diane St Germain, Andrea Denicoff, et al. · Cancer · 19
PDF
Update on Enrollment of Older Adults Onto National Cancer Institute National Clinical Trials Network Trials
2022 · Grace E Mishkin, Andrea M Denicoff, et al. · JNCI Monographs · 17
PDF
COVID-19 severity by vaccination status in the NCI COVID-19 and Cancer Patients Study (NCCAPS)
2023 · Ana F Best, Melissa Bowman, et al. · JNCI Journal of the National Cancer Institute · 10
PDF
Transforming the Early Drug Development Paradigm at the National Cancer Institute: The Formation of NCI's Experimental Therapeutics Clinical Trials Network (ETCTN)
2019 · Holly A. Massett, Grace Mishkin, et al. · Clinical Cancer Research · 9
Risk Factors for COVID-19–Related Hospitalization and Death in Patients With Cancer
2025 · Brian I. Rini, Ana F. Best, et al. · JAMA Oncology · 6
Initial reporting from the prospective National Cancer Institute (NCI) COVID-19 in Cancer Patients Study (NCCAPS).
2021 · Larissa A. Korde, Ana F. Best, et al. · Journal of Clinical Oncology · 5
Drivers of Clinical Trial Participation—Demographics, Disparities, and Eligibility Criteria
2019 · Grace Mishkin, Fernanda Arnaldez, et al. · JAMA Oncology · 5
Biomarker Development: Bedside to Bench
2022 · Grace E. Mishkin, Elise C. Kohn · Clinical Cancer Research · 4
National Cancer Institute (NCI) implementation of the American Society of Clinical Oncology (ASCO) and Friends of Cancer Research (Friends) broadening clinical trials eligibility criteria.
2021 · Andrea M. Denicoff, S. Percy Ivy, et al. · Journal of Clinical Oncology · 4
P1.01-12 Trends in the National Cancer Institute (NCI) Sponsored Lung Cancer Clinical Trials Pre and Post NCI’s National Clinical Trials Network (NCTN)
2019 · S. Malik, G. Mishkin, et al. · Journal of Thoracic Oncology · 3
PDF
A Network Analysis of the GamerGate Movement
2018 · Aitalohi Amaize, Andrea Castillo, et al. · Human-computer interaction series · 3
Creating a national collaborative strategy to enhance trial accrual in NCI’s National Clinical Trials Network (NCTN) in the era of precision medicine.
2015 · Andrea Denicoff, Holly A Massett, et al. · Journal of Clinical Oncology · 3
NCI’s national treatment trial networks: Experience and adaptations during COVID-19.
2021 · Margaret M. Mooney, Grace E. Mishkin, et al. · Journal of Clinical Oncology · 1
Adverse events (AEs) in early phase cancer clinical trials.
2018 · Grace Mishkin, Andrea Denicoff, et al. · Journal of Clinical Oncology · 1
A Randomized Controlled Study Comparing the National Cancer Institute's Original and Revised Consent Form Templates.
2017 · Holly A Masset, Michelle Hiser, et al. · PubMed · 1
National coverage analyses for NCI clinical trials: A pilot project to reduce participation barriers.
2017 · Andrea Denicoff, Grace Mishkin, et al. · Journal of Clinical Oncology · 1
Trends in Diversity in National Cancer Institute-Sponsored Early Phase Clinical Trials (2000-2023): A Cohort Study
2024 · Maria Farooq, Shanda Finnigan, et al. · SSRN Electronic Journal
Initial report on hospitalized cancer patients with COVID-19 from the National Cancer Institute (NCI) COVID-19 in Cancer Patients Study (NCCAPS).
2021 · Nicholas M. Mark, Ana F. Best, et al. · Journal of Clinical Oncology
Analysis of potential disparities in lung cancer clinical trial participation among Medicare beneficiaries.
2021 · Grace E. Mishkin, Luisa Franzini · Journal of Clinical Oncology
Novel Immunotherapy Agents in Oncology: Generalizability of Trial Results and Drivers of Clinical Utilization
2021 · Mishkin, Grace · University Libraries (University of Maryland)
PDF
Transparency around disapproval reasons of early-phase trial proposals submitted to the National Cancer Institute (NCI).
2017 · Holly A. Massett, Amy Gravell, et al. · Journal of Clinical Oncology
Works count: 30
Citation count: 219
H-index: 8
I10-index: 7
Year
Topic
Type